elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34326476-6A04181B-7121-42A7-8BE8-337619E38318
Q34326476-6A04181B-7121-42A7-8BE8-337619E38318
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34326476-6A04181B-7121-42A7-8BE8-337619E38318
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors.
P2860
Q34326476-6A04181B-7121-42A7-8BE8-337619E38318
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34326476-6A04181B-7121-42A7-8BE8-337619E38318
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e3708b820ab0f02c6e23aaa5c8f843b7c6265d4e
P2860
CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.